|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Methylcyclohexanol |
CAS 25639-42-3 | ||
CH3C6H10OH |
RTECS GW0175000 | ||
|
Synonyms & Trade Names Hexahydrocresol, Hexahydromethylphenol |
DOT ID & Guide 2617 129 |
||
Exposure
|
NIOSH REL: TWA 50 ppm (235 mg/m3) | ||
| OSHA PEL†: TWA 100 ppm (470 mg/m3) | |||
| IDLH 500 ppm See: 25639423 | Conversion 1 ppm = 4.67 mg/m3 | ||
|
Physical Description Straw-colored liquid with a weak odor like coconut oil. |
|||
|
MW: 114.2 |
BP: 311-356°F |
FRZ: -58°F |
Sol: 4% |
|
VP(86°F): 2 mmHg |
IP: 9.80 eV |
|
Sp.Gr: 0.92 |
|
Fl.P: 149-158°F |
UEL: ? |
LEL: ? |
|
| Class IIIA Combustible Liquid: Fl.P. at or above 140°F and below 200°F. | |||
|
Incompatibilities & Reactivities Strong oxidizers |
|||
|
Measurement Methods NIOSH 1404 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH Up to 500 ppm: (APF = 10) Any supplied-air respirator* (APF = 50) Any self-contained breathing apparatus with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin, upper respiratory system; headache; in animals: narcosis; liver, kidney damage | |
|
Target Organs
Eyes, skin, respiratory system, central nervous system, kidneys, liver |
|
| See also: INTRODUCTION See ICSC CARD: 0292 |